The difficult-to-treat electroconvulsive therapy patient - Strategies for augmenting outcomes

Journal of Affective Disorders

Volumn 124, Issue 3, 2010, Pages 219-227

  Loo, Colleen K ^a,b,c   Kaill, Andrew ^b   Paton, Pauline ^b   Simpson, Brett ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c BLACK DOG INSTITUTE   (Australia)

Author keywords

Depression; Electroconvulsive therapy; Hyperventilation; Remifentanil; Treatment resistance

Indexed keywords

AMLODIPINE; DICLOFENAC; FUROSEMIDE; METHOTREXATE; METOPROLOL; MIANSERIN; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PREDNISONE; REMIFENTANIL; RISPERIDONE; THIOPENTAL; VENLAFAXINE;

AGED; AGITATION; ANESTHESIA INDUCTION; CASE REPORT; CLINICAL EFFECTIVENESS; CONFLICT OF INTEREST; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYNDROME; FEMALE; FUNDING; HOSPITAL ADMISSION; HUMAN; HYPERVENTILATION; HYPONATREMIA; LEUKOPENIA; MAJOR DEPRESSION; MARRIED WOMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEIZURE; SOMATIC DELUSION; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT WITHDRAWAL;

AGED; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL LOBE; HUMANS; HYPERVENTILATION; MENTAL STATUS SCHEDULE; PIPERIDINES; RECURRENCE; RETREATMENT; SUICIDE, ATTEMPTED; TEMPORAL LOBE;

EID: 77953811729     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.07.011     Document Type: Review

References (49)

1. Akcaboy Z.N., Akcaboy E.Y., Yigitbasl B., Bayam G., Dikmen B., Gogus N., and Dilbaz N. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaesthesiol. Scand. 49 (2005) 1068-1071
2. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging: A Task Force Report of the American Psychiatric Association. Second Edition (2001), American Psychiatric Association (APA, Washington, DC
3. Andersen F.A., Arsland D., and Holst-Larsen H. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol. Scand. 45 (2001) 830-833
4. Baghai T.C., Marcuse A., Brosch M., Schüle C., Eser D., Nothdurfter C., Steng Y., Noack I., Pietschmann K., Möller H.J., and Rupprecht R. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J. Biol. Psychiatry 7 (2006) 82-90
5. Bergsholm P., Gran L., and Bleie H. Seizure duration in unilateral electroconvulsive therapy. Acta Psychiatr. Scand. 69 (1984) 121-128
6. Chater S.N., and Simpson K.H. Effect of passive hyperventilation on seizure duration in patients undergoing electroconvulsive therapy. Br. J. Anaesth. 60 (1988) 70-73
7. Ding Z., and White P. Anaesthesia for electroconvulsive therapy. Anesth. Analg. 95 (2002) 1351-1364
8. Dinwiddie S.H., and Isenberg K.E. Combined alfentanil-methohexital anesthesia in electroconvulsive therapy. Convuls. Ther. 11 (1995) 170-176
9. Dunlop E. Combination of antidepressant with electroshock therapy. Dis. Nerv. Syst. 21 (1960) 513-514
10. Folstein M., Folstein S., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 12 (1975) 189-198
11. Gangadhar B.N., Janakiramaiah N., Subbakrishna D.K., Praveen J., and Reddy A.K. Twice versus thrice weekly ECT in melancholia: a double-blind prospective comparison. J. Affect. Disord. 27 (1993) 273-278
12. Gonzalez-Pinto A., Gutierrez M., Gonzalez N., Elizagarate E., Perez de Heredia J.L., and Mico J.A. Efficacy and safety of venlafaxine - ECT combination in treatment-resistant depression. J. Neuropsychiatry Clin. Neurosci. 14 (2002) 206-209
13. Guaranha M.S.B., Garzon E., and Buchpiguel C.A. Hyperventilation revisited: physiological effects and efficacy on focal seizure activation in the era of video-EEG monitoring. Epilepsia 46 (2005) 69-75
14. Holmberg G. The factor of hypoxaemia in electroshock therapy. Am. J. Psychiatry 110 (1953) 115-118
15. Holmes M.D., Dewaraja A.S., and Vanhatalo S. Does hyperventilation elicit epileptic seizures?. Epilepsia 45 (2004) 618-620
16. Hoshi Y., Okuhara H., Nakane S., Hayakawa K., Kobayashi N., and Kajii N. Re-evaluation of the hypoxia theory as the mechanism of hyperventilation-induced EEG slowing. Pediatr. Neurol. 21 (1999) 638-643
17. Imlah N.W., Ryan E., and Harrington J.A. The influence of antidepressant drugs in the response to electroconvulsive therapy and subsequent relapse rates. Neuropsychopharmacology 4 (1965) 438-442
18. Kay D., Fahy T., and Garside R. A seven-month double-blind trial of amitryptyline and diazepam in ECT-treated depressed patients. Br. J. Psychiatry 117 (1970) 667-671
19. Kellner C.H., Monroe R.R., Pritchett J., Jarrell M.P., Bernstein H.J., and Burns C.M. Weekly ECT in geriatric depression. Convuls. Ther. 8 (1992) 245-252
20. Lerer B., Shapira B., Calev A., Tubi N., Drexler H., Kindler S., Lidsky D., and Schwartz J.E. Antidepressant and cognitive effects of twice- versus three-times-weekly ECT. Am. J. Psychiatry 152 (1995) 564-570
21. Locala J.A., Irefin S.A., Malone D., Cywinski J.B., Samuel S.W., and Naugle R. The comparative hemodynamic effects of methohexital and remifentanil in electroconvulsive therapy. J. ECT 21 (2005) 12-15
22. Loo C., Sheehan P., Pigot M., and Lyndon W. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT. J. Affect. Disord. 102 (2007) 277-281
23. Mayur P.M., Gangadhar B.N., Subbakrishna D.K., and Janakiramaiah N. Discontinuation of antidepressant drugs during electroconvulsive therapy: a controlled study. J. Affect. Disord. 58 (2000) 37-41
24. McAllister D.A., Perri M.G., Jordan R.C., Rauscher F.P., and Sattin A. Effects of ECT given two vs. three times weekly. Psychiatry Res. 21 (1987) 63-69
25. Milne S.E., Kenny G.N., and Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br. J. Anaesth. 90 (2003) 623-629
26. Monaco J.T., and Delaplaine R.P. Tranylcypromine with ECT. Am. J. Psychiatry 120 (1964) 1003
27. Muller D. Nardil (Phenelzine) as a potentiator of electroconvulsive therapy (ECT) 2. A survey of outpatient ECT. J. Ment. Sci. 107 (1961) 994-996
28. Nelson J.P., and Benjamin L. Efficacy and safety of combined ECT and tricyclic antidepressant drugs in the treatment of depressed geriatric patients. Convuls. Ther. 5 (1989) 321-329
29. Nguyen T.T., Chhibber A.K., Lustik S.J., Kolano J.W., Dillon P.J., and Guttmacher L.B. Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br. J. Anaesth. 79 (1997) 801-803
30. Pande A.C., Shea J., Shettar S., Grunhaus L.J., and Haskett R.F. Effect of hyperventilation on seizure length during electroconvulsive therapy. Bio. Psychiatry 27 (1990) 799-801
31. Prudic J., Haskett R.F., Mulsant B., Malone K.M., Pettinati H.M., Stephens S., Greenberg R., Rifas S.L., and Sackeim H.A. Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry. 153 (1996) 985-992
32. Rasanen J., Martin D.J., Downs J.B., and Hodges M.R. Oxygen supplementation during electroconvulsive therapy. Br. J. Anaesth. 61 (1988) 593-597
33. Rasimas J.J., Stevens S.R., and Rasmussen K.G. Seizure length in electroconvulsive therapy as a function of age, sex and treatment number. J. ECT 23 (2007) 14-16
34. Recart A., Rawal S., White P.F., Byerly S., and Thorton L. The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy. Anesth. Analg. 96 (2003) 1047-1050
35. Royal Australian and New Zealand College of Psychiatrists. Clinical Memorandum on Electroconvulsive Therapy (2005), Royal Australian and New Zealand College of Psychiatrists (RANZCP), Melbourne February
36. Royal College of Psychiatrists. The ECT Handbook: The Third Report of the Royal College of Psychiatrists' Special Committee on ECT. Second Edition (2005), Royal College of Psychiatrists, London, UK
37. Sackeim H.A. The efficacy of electroconvulsive therapy. Discussion of part I. Ann. N. Y. Acad. Sci. 462 (1986) 70-75
38. Sackeim H.A. The anticonvulsant hypothesis of the mechanism of action of ECT: current status. J. ECT 15 (1999) 5-26
39. Sackeim H. Convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clin. Neurosci. Res. 4 (2004) 39-57
40. Sackeim H.A., Prudic J., Devanand D.P., Kiersky J.E., Fitzsimons L., Moody B.J., McElhiney M.C., Coleman E.A., and Settembrino J.M. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N. Engl. J. Med. 328 (1993) 839-846
41. Sackeim H.A., Prudic J., Devanand D.P., Nobler M.S., Lisanby S.H., Peyser S., Fitzsimons L., Moody B.J., and Clark J. A prospective, randomised, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch. Gen. Psychiatry 57 (2000) 425-434
42. Sackeim H.A., Dillingham E., Prudic J., Cooper T., McCall V., Rosenquist P., Isenberg K., Garcia K., Mulsant B., and Haskett R. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes. Arch. Gen. Psychiatry 66 (2009) 729-737
43. Sawayama E., Takahashi M., Inoue A., Nakajima K., Kano A., Sawayama T., Okutomi T., and Miyaoka H. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy. J. ECT 24 (2008) 195-198
44. Seager C.P., and Bird R.L. Imipramine with electrical treatment in depression - a controlled trial. J. Ment. Sci. 108 (1962) 704-707
45. Smith D.L., Angst M.S., Brock-Utne J.G., and DeBattista C. Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. Acta. Anaesthesiol. Scand. 47 (2003) 1064-1066
46. Stromgren L.S. Therapeutic results in brief-interval unilateral ECT. Acta Psychiatr. Scand. 52 (1975) 246-255
47. Sullivan P.M., Sinz E.H., Gunel E., and Kofke W.A. A retrospective comparison of remifentanil versus methohexital for anesthesia in electroconvulsive therapy. J. ECT 20 (2004) 219-224
48. Vishne T., Aronov S., Amiaz R., Etchin A., and Grunhaus L. Remifentanil supplementation of propofol during ECT: effect on seizure duration and cardiovascular stability. J. ECT 21 (2005) 235-238
49. Wilson I.C., Vernon J.T., Guin T., and Sandifer M.G. A controlled study of treatments of depression. J. Neuropsychiatry 4 (1963) 331-337